Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

They have (3) phase 3 studies, the 1200 patient study you noted the 600 patient study entitled ¨Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease¨, and Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease Evidently the same drug in all 3 studies.

https://clinicaltrials.gov/ct2/show/study/NCT03440385?term=Ozanimod&rank=5&show_locs=Y#locn

https://clinicaltrials.gov/ct2/show/NCT03440372?term=Ozanimod&draw=3&rank=6